Quantum Biopharma Ltd. Files October 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Oct 23, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its Oct 2025 6-K, confirming 20-F annual filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 23, 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, is a pharmaceutical preparations company. This filing is a report of a foreign private issuer for the month of October 2025, and the company will file its annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's regulatory reporting status as a foreign private issuer. It confirms their adherence to SEC filing requirements, specifically the use of Form 20-F for annual reports.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would indicate increased risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- October 23, 2025 (date) — Filing date of the 6-K report
- Toronto, Ontario (location) — Location of the company's principal executive office
- Form 20-F (document) — Annual report form to be filed by the company
- Form 6-K (document) — Report of Foreign Private Issuer
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2025.
What is the company's name and former name?
The company's current name is Quantum Biopharma Ltd., and its former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. located?
The company's principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files or will file annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The Standard Industrial Classification code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-10-23 08:15:04
Filing Documents
- f6k_102325.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 12KB
- image_001.jpg (GRAPHIC) — 6KB
- 0001171843-25-006619.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 23, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 23, 2025